BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11408942)

  • 1. UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice.
    Redkar AA; Meadows GG; Daoud SS
    Int J Oncol; 2001 Jul; 19(1):193-9. PubMed ID: 11408942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent.
    Chen X; Lowe M; Keyomarsi K
    Oncogene; 1999 Oct; 18(41):5691-702. PubMed ID: 10577141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.
    Bunch RT; Eastman A
    Clin Cancer Res; 1996 May; 2(5):791-7. PubMed ID: 9816232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of p53 in growth arrest and apoptosis on combined treatment of human Mammary epithelial cells with topotecan and UCN-01.
    Redkar A; Mixter P; Daoud SS
    J Exp Ther Oncol; 2004 Oct; 4(3):213-22. PubMed ID: 15724841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).
    Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S
    Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
    Wang Q; Worland PJ; Clark JL; Carlson BA; Sausville EA
    Cell Growth Differ; 1995 Aug; 6(8):927-36. PubMed ID: 8547221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
    Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
    Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
    Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
    Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.
    Seynaeve CM; Stetler-Stevenson M; Sebers S; Kaur G; Sausville EA; Worland PJ
    Cancer Res; 1993 May; 53(9):2081-6. PubMed ID: 7683251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.
    Akinaga S; Nomura K; Gomi K; Okabe M
    Cancer Chemother Pharmacol; 1994; 33(4):273-80. PubMed ID: 7506638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
    Shao RG; Cao CX; Shimizu T; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1997 Sep; 57(18):4029-35. PubMed ID: 9307289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.
    Bozko P; Larsen AK; Raymond E; Skladanowski A
    Acta Biochim Pol; 2002; 49(1):109-19. PubMed ID: 12136930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCN-01 (7-hydroxystaurosporine) induces apoptosis and G1 arrest of both primary and metastatic oral cancer cell lines in vitro.
    Otsubo A; Bhawal UK; Nomura Y; Mitani Y; Ozawa K; Kuniyasu H; Sugiyama M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):391-7. PubMed ID: 17321452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
    Akinaga S; Gomi K; Morimoto M; Tamaoki T; Okabe M
    Cancer Res; 1991 Sep; 51(18):4888-92. PubMed ID: 1893379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines.
    Dasmahapatra GP; Didolkar P; Alley MC; Ghosh S; Sausville EA; Roy KK
    Clin Cancer Res; 2004 Aug; 10(15):5242-52. PubMed ID: 15297428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells.
    Jones CB; Clements MK; Redkar A; Daoud SS
    Int J Oncol; 2000 Nov; 17(5):1043-51. PubMed ID: 11029511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
    Takahashi I; Kobayashi E; Nakano H; Murakata C; Saitoh H; Suzuki K; Tamaoki T
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1218-21. PubMed ID: 2262903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.